Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

被引：4

作者：

Uutela, Aki ^{[1
,2
,3
]}

Nordin, Arno ^{[1
,2
]}

Osterlund, Emerik ^{[1
,2
,4
]}

Halonen, Paeivi ^{[2
,5
]}

Kallio, Raija ^{[6
]}

Soveri, Leena-Maija ^{[7
,8
]}

Salminen, Tapio ^{[9
,10
]}

Algars, Annika ^{[11
,12
]}

Ristimaki, Ari ^{[2
,13
]}

Ovissi, Ali ^{[2
,14
]}

Lamminmaki, Annamarja ^{[15
,16
]}

Muhonen, Timo ^{[8
,17
]}

Kononen, Juha ^{[18
,19
]}

Ristamaki, Raija ^{[11
,12
]}

Heerva, Eetu ^{[11
,12
]}

Stedt, Hanna ^{[15
,16
]}

Lehtomaki, Kaisa ^{[9
,10
]}

Kytola, Soili ^{[2
,20
]}

Sundstrom, Jari ^{[12
,21
]}

Makinen, Markus J. ^{[22
]}

Nieminen, Lasse ^{[10
]}

Kuopio, Teijo

Keinanen, Mauri

Osterlund, Pia ^{[2
,5
,9
,10
]}

Isoniemi, Helena ^{[1
,2
]}

机构：

[1] Helsinki Univ Hosp, Abdominal Ctr, Dept Transplantat & Liver Surg, Helsinki, Finland

[2] Univ Helsinki, Helsinki, Finland

[3] Royal Infirm Edinburgh NHS Trust, Dept Transplant & Hepatopancreatobiliary Surg, Edinburgh, Scotland

[4] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden

[5] Helsinki Univ Hosp, Dept Oncol, Comprehens Canc Ctr, Helsinki, Finland

[6] Oulu Univ Hosp, Dept Oncol, Oulu, Finland

[7] Joint Municipal Author Hlth Care & Social Serv Kes, Home Care Geriatr Clin & Palliat Care, Hyvinkaa, Uusimaa, Finland

[8] Univ Helsinki, Fac Med, Helsinki, Finland

[9] Tampere Univ Hosp, Dept Oncol, Tampere, Finland

[10] Univ Tampere, Tampere, Finland

[11] Turku Univ Hosp, Dept Oncol, Turku, Finland

[12] Univ Turku, Dept Pathol, Turku, Finland

[13] Helsinki Univ Hosp, HUS Diagnost Ctr & Appl Tumour Genom, Dept Pathol, Res Programmes Unit, Helsinki, Finland

[14] Helsinki Univ Hosp, HUS Med Imaging Ctr, Dept Radiol, Helsinki, Finland

[15] Kuopio Univ Hosp, Dept Oncol, Kuopio, Finland

[16] Univ Eastern Finland, Abdominal Ctr, Transplantat & Liver Surg, Haartmaninkatu 4,Bldg 1, Kuopio 00029, Finland

[17] South Carel Cent Hosp, Dept Oncol, Haartmaninkatu 4,Bldg 1, Lappeenranta 00029, Finland

[18] Cent Finland Hosp Nova, Dept Oncol, Jyvaskyla, Finland

[19] Docrates Canc Ctr, Helsinki, Finland

[20] Helsinki Univ Hosp, HUS Diagnost Ctr, Dept Genet, HUSLAB, Helsinki, Finland

[21] Turku Univ Hosp, Dept Pathol, Turku, Finland

[22] Oulu Univ Hosp, Dept Pathol, Oulu, Finland

来源：

BRITISH JOURNAL OF SURGERY | 2023年 / 110卷 / 08期

关键词：

POOLED ANALYSIS; CANCER; BEVACIZUMAB; FOLFOXIRI; KRAS;

D O I：

10.1093/bjs/znac424

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：931 / 935

页数：5

共 50 条

[31] Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status
Watkins, D. J.
Chau, I.
Cunningham, D.
Mudan, S. S.
Karanjia, N.
Brown, G.
Ashley, S.
Norman, A. R.
Gillbanks, A.
BRITISH JOURNAL OF CANCER, 2010, 102 (02) : 255 - 261
[32] Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status
D J Watkins
I Chau
D Cunningham
S S Mudan
N Karanjia
G Brown
S Ashley
A R Norman
A Gillbanks
British Journal of Cancer, 2010, 102 : 255 - 261
[33] Incorporating RAS mutation status into the Clinical Risk Score better predicts survival after resection of colorectal liver metastases
Jones, Robert
Malik, Hassan
Fenwick, Stephen
Poston, Graeme
Brudvik, Kristoffer
Giuliante, Felice
Shindoh, Junichi
Passot, Guillaume
Dagenborg, Vegar Johansen
Fretland, Asmund Avdem
Rosok, Bard
Conrad, Claudius
Aloia, Thomas
Bjornbeth, Bjorn Atle
Vauthey, Jean-Nicolas
BRITISH JOURNAL OF SURGERY, 2016, 103 : 7 - 7
[34] A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status
Kawaguchi, Yoshikuni
Kopetz, Scott
Lillemoe, Heather A.
Hwang, Hyunsoo
Wang, Xuemei
Tzeng, Ching-Wei D.
Chun, Yun Shin
Aloia, Thomas A.
Vauthey, Jean-Nicolas
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (11): : 1500 - +
[35] TUMOR RECURRENCE AFTER R0 RESECTION OF COLORECTAL LIVER METASTASES - INCIDENCE, RESECTABILITY, AND PROGNOSIS
SCHEELE, J
STANGL, R
SCHMIDT, K
ALTENDORFHOFMANN, A
CHIRURG, 1995, 66 (10): : 965 - 973
[36] Surgical Resection of Liver Metastases From Colorectal Carcinoma - Survival According to Radical Liver Resection and to Prognostic Factors
Fantola, G.
Tondolo, V.
Mantovani, G.
Runfola, M.
Zamboni, F.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S414 - S414
[37] BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
M Schirripa
F Bergamo
C Cremolini
M Casagrande
S Lonardi
G Aprile
D Yang
F Marmorino
G Pasquini
E Sensi
C Lupi
G De Maglio
N Borrelli
S Pizzolitto
G Fasola
R Bertorelle
M Rugge
G Fontanini
V Zagonel
F Loupakis
A Falcone
British Journal of Cancer, 2015, 112 : 1921 - 1928
[38] The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases
Hatta, Ayiesha Ahmad Zalmani
Pathanki, Adithya M.
Hodson, James
Sutcliffe, Robert P.
Marudanayagam, Ravi
Roberts, Keith J.
Chatzizacharias, Nikolaos
Isaac, John
Muiesan, Paolo
Taniere, Phillipe
Mirza, Darius F.
Dasari, Bobby V. M.
HPB, 2021, 23 (01) : 90 - 98
[39] Significance of poor performance status after resection of colorectal liver metastases
Peter Strandberg Holka
Sam Eriksson
Jakob Eberhard
Magnus Bergenfeldt
Gert Lindell
Christian Sturesson
World Journal of Surgical Oncology, 16
[40] Significance of poor performance status after resection of colorectal liver metastases
Holka, Peter Strandberg
Eriksson, Sam
Eberhard, Jakob
Bergenfeldt, Magnus
Lindell, Gert
Sturesson, Christian
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16 : 3

← 1 2 3 4 5 →